Denosumab

Romosozumab Versus Denosumab in Glucocorticoid-induced Osteoporosis: an Extended Observation of a Randomized Controlled Trial at 48 Months

Markers of Osteoporosis in Cystic Fibrosis

Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI

Denosumab Strategy for Liver Cancer With Bone Metastases

Anabolic Therapy in Postmenopausal Osteoporosis

RANKL Inhibition and Mammographic Breast Density

Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

Denosumab for Smoldering Multiple Myeloma

Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia

Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture

Muscle Impact of Treating Osteoporosis

NAPO - Novel Approach for Oligospermia

Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis

The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity

Efficacy and Safety of Combination Denosumab With Eldecalcitol for Postmenopausal Women With Osteoporosis.(ESCORT)

Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery

Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI